- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 742.68M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 742.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 740.44M sh |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $0 |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $1.62M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.31M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.38M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.24M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$108.45M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$106.01M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $6.29M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.75M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $126.08M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $121.67M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $3.34M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.01M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $11.86M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.96M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.81M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.96M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $39.3K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.53M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.11M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.73M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$2.01M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $40.97K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $119.59K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $202.45K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $528.17K |
| Revenue | Q1 2026 · Mar 31, 2026 | $243.41K |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $647.77K |